Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 13 | 2023 | 572 | 1.690 |
Why?
|
| Autoimmunity | 10 | 2021 | 238 | 1.240 |
Why?
|
| Receptors, Antigen, B-Cell | 6 | 2017 | 60 | 1.150 |
Why?
|
| Autoimmune Diseases | 5 | 2019 | 230 | 1.090 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2023 | 165 | 1.040 |
Why?
|
| Toll-Like Receptor 9 | 7 | 2023 | 211 | 0.930 |
Why?
|
| Lymphocyte Activation | 9 | 2023 | 758 | 0.930 |
Why?
|
| Antibodies, Antinuclear | 3 | 2022 | 38 | 0.910 |
Why?
|
| Interferon Type I | 3 | 2019 | 187 | 0.750 |
Why?
|
| Toll-Like Receptor 7 | 4 | 2023 | 103 | 0.660 |
Why?
|
| Nucleic Acids | 2 | 2019 | 60 | 0.610 |
Why?
|
| Toll-Like Receptors | 3 | 2016 | 431 | 0.570 |
Why?
|
| Inflammation | 4 | 2023 | 1147 | 0.540 |
Why?
|
| Rheumatoid Factor | 2 | 2015 | 13 | 0.530 |
Why?
|
| Interferon Regulatory Factors | 3 | 2021 | 43 | 0.390 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 126 | 0.390 |
Why?
|
| Disease Susceptibility | 2 | 2022 | 165 | 0.340 |
Why?
|
| Mice | 19 | 2023 | 10844 | 0.340 |
Why?
|
| Endodeoxyribonucleases | 4 | 2019 | 44 | 0.330 |
Why?
|
| DNA | 5 | 2017 | 837 | 0.330 |
Why?
|
| Mice, Knockout | 11 | 2017 | 2109 | 0.320 |
Why?
|
| Autoantibodies | 5 | 2023 | 182 | 0.310 |
Why?
|
| Animals | 23 | 2023 | 20663 | 0.310 |
Why?
|
| Immunoglobulin Light Chains, Surrogate | 1 | 2009 | 1 | 0.310 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2009 | 10 | 0.310 |
Why?
|
| RNA Editing | 1 | 2009 | 23 | 0.300 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2009 | 46 | 0.300 |
Why?
|
| Mice, Inbred BALB C | 5 | 2016 | 883 | 0.300 |
Why?
|
| Mice, Transgenic | 6 | 2015 | 1277 | 0.280 |
Why?
|
| Autoantigens | 4 | 2023 | 137 | 0.270 |
Why?
|
| Cell Differentiation | 5 | 2017 | 1353 | 0.240 |
Why?
|
| Flow Cytometry | 6 | 2016 | 664 | 0.230 |
Why?
|
| B-Cell Activating Factor | 2 | 2017 | 9 | 0.220 |
Why?
|
| Platelet Factor 4 | 1 | 2023 | 12 | 0.210 |
Why?
|
| Scleroderma, Systemic | 1 | 2023 | 22 | 0.210 |
Why?
|
| Bone Resorption | 1 | 2023 | 42 | 0.200 |
Why?
|
| Lymphoma, B-Cell | 1 | 2023 | 61 | 0.200 |
Why?
|
| Membrane Proteins | 3 | 2016 | 895 | 0.180 |
Why?
|
| Virus Diseases | 1 | 2012 | 120 | 0.170 |
Why?
|
| Influenza A virus | 1 | 2021 | 123 | 0.170 |
Why?
|
| Interferon-gamma | 2 | 2019 | 567 | 0.170 |
Why?
|
| HMGB1 Protein | 1 | 2010 | 25 | 0.160 |
Why?
|
| Interleukin-6 | 1 | 2021 | 321 | 0.160 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 23 | 0.160 |
Why?
|
| Exodeoxyribonucleases | 1 | 2019 | 29 | 0.160 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2023 | 337 | 0.150 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 59 | 0.150 |
Why?
|
| Influenza, Human | 1 | 2021 | 208 | 0.150 |
Why?
|
| Th1 Cells | 1 | 2019 | 173 | 0.150 |
Why?
|
| Interferon-beta | 1 | 2009 | 80 | 0.150 |
Why?
|
| Immunity, Innate | 2 | 2021 | 795 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 641 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2010 | 217 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 615 | 0.150 |
Why?
|
| Cell Proliferation | 3 | 2015 | 988 | 0.140 |
Why?
|
| Phosphoproteins | 1 | 2019 | 220 | 0.140 |
Why?
|
| Endosomes | 2 | 2016 | 177 | 0.140 |
Why?
|
| Ligands | 4 | 2023 | 416 | 0.140 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 5 | 0.130 |
Why?
|
| Antigens | 1 | 2017 | 147 | 0.130 |
Why?
|
| Lupus Nephritis | 1 | 2016 | 35 | 0.120 |
Why?
|
| Arthritis, Experimental | 1 | 2016 | 29 | 0.120 |
Why?
|
| Macrophages | 1 | 2021 | 1039 | 0.120 |
Why?
|
| Myeloid Cells | 1 | 2016 | 94 | 0.120 |
Why?
|
| CD2 Antigens | 1 | 2005 | 3 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 719 | 0.120 |
Why?
|
| Stromal Cells | 1 | 2016 | 68 | 0.120 |
Why?
|
| CD3 Complex | 1 | 2005 | 65 | 0.120 |
Why?
|
| Arthritis | 1 | 2015 | 53 | 0.120 |
Why?
|
| Syndecan-1 | 1 | 2015 | 9 | 0.120 |
Why?
|
| Mice, SCID | 4 | 2009 | 519 | 0.120 |
Why?
|
| Cell Lineage | 1 | 2016 | 270 | 0.110 |
Why?
|
| Plasma Cells | 1 | 2015 | 52 | 0.110 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 284 | 0.110 |
Why?
|
| T-Lymphocytes | 3 | 2007 | 1007 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 297 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2157 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 542 | 0.100 |
Why?
|
| Mice, Inbred CBA | 1 | 2013 | 83 | 0.100 |
Why?
|
| Dendritic Cells | 2 | 2015 | 525 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 3396 | 0.100 |
Why?
|
| Humans | 9 | 2023 | 63445 | 0.100 |
Why?
|
| GTPase-Activating Proteins | 1 | 2013 | 69 | 0.100 |
Why?
|
| RNA | 1 | 2015 | 423 | 0.090 |
Why?
|
| Transcriptome | 1 | 2015 | 387 | 0.090 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 2187 | 0.090 |
Why?
|
| Bone Marrow Cells | 2 | 2008 | 238 | 0.080 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2009 | 9 | 0.080 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2009 | 10 | 0.080 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 2009 | 13 | 0.080 |
Why?
|
| Immunoglobulin Class Switching | 2 | 2007 | 83 | 0.080 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2009 | 34 | 0.080 |
Why?
|
| Complementarity Determining Regions | 1 | 2009 | 38 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2023 | 1186 | 0.070 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 1 | 2008 | 5 | 0.070 |
Why?
|
| Receptor, Interferon alpha-beta | 2 | 2015 | 53 | 0.070 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2007 | 12 | 0.070 |
Why?
|
| Chromatin | 2 | 2023 | 608 | 0.060 |
Why?
|
| Catalytic Domain | 1 | 2007 | 199 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2007 | 246 | 0.060 |
Why?
|
| Membrane Transport Proteins | 2 | 2016 | 135 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 454 | 0.060 |
Why?
|
| Osteoclasts | 1 | 2023 | 48 | 0.050 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2023 | 204 | 0.050 |
Why?
|
| beta Catenin | 1 | 2023 | 96 | 0.050 |
Why?
|
| Male | 4 | 2021 | 29891 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2023 | 112 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 778 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2023 | 139 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2023 | 198 | 0.050 |
Why?
|
| Osteogenesis | 1 | 2023 | 143 | 0.050 |
Why?
|
| Nasal Lavage | 1 | 2021 | 2 | 0.050 |
Why?
|
| Female | 4 | 2021 | 32880 | 0.050 |
Why?
|
| Gain of Function Mutation | 1 | 2021 | 15 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1617 | 0.040 |
Why?
|
| Germinal Center | 1 | 2021 | 39 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 100 | 0.040 |
Why?
|
| Antibody Specificity | 2 | 2015 | 102 | 0.040 |
Why?
|
| Thymus Gland | 2 | 2007 | 233 | 0.040 |
Why?
|
| Phenotype | 2 | 2015 | 1207 | 0.040 |
Why?
|
| Cell Survival | 1 | 2012 | 575 | 0.040 |
Why?
|
| Antigen-Antibody Complex | 1 | 2010 | 52 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 467 | 0.040 |
Why?
|
| Genotype | 2 | 2015 | 663 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 3035 | 0.040 |
Why?
|
| T-Box Domain Proteins | 1 | 2017 | 38 | 0.030 |
Why?
|
| CD40 Antigens | 1 | 2017 | 60 | 0.030 |
Why?
|
| Interleukins | 1 | 2017 | 80 | 0.030 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2016 | 12 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 149 | 0.030 |
Why?
|
| Terpenes | 1 | 2016 | 27 | 0.030 |
Why?
|
| Spleen | 2 | 2008 | 483 | 0.030 |
Why?
|
| Radiation Chimera | 1 | 2016 | 58 | 0.030 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2015 | 6 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2015 | 24 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 226 | 0.030 |
Why?
|
| Cytokines | 1 | 2009 | 935 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 517 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2015 | 97 | 0.030 |
Why?
|
| Interferons | 1 | 2015 | 73 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 378 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 2040 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2013 | 60 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 669 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 16824 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2005 | 1358 | 0.020 |
Why?
|
| Lymphocyte Transfusion | 1 | 2008 | 37 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2008 | 19 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 115 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 195 | 0.020 |
Why?
|
| Breeding | 1 | 2007 | 26 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2008 | 180 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2007 | 77 | 0.020 |
Why?
|
| Cell Count | 1 | 2007 | 132 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2007 | 148 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 2006 | 34 | 0.020 |
Why?
|
| Transgenes | 1 | 2007 | 187 | 0.020 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2006 | 54 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 2612 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 459 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1079 | 0.010 |
Why?
|